Literature DB >> 33095941

Regulatory functions of NK cells during infections and cancer.

Norberto W Zwirner1,2, Carolina I Domaica1, Mercedes B Fuertes1.   

Abstract

After recognition, NK cells can kill susceptible target cells through perforin-dependent mechanisms or by inducing death receptor-mediated apoptosis, and they can also secrete cytokines that are pivotal for immunomodulation. Despite the critical role as effector cells against tumors and virus-infected cells, NK cells have been implicated in the regulation of T cell-mediated responses in different models of autoimmunity, transplantation, and viral infections. Here, we review the mechanisms described for NK cell-mediated inhibition of adaptive immune responses, with spotlight on the emerging evidence of their regulatory role that shapes antitumor immune responses. ©2020 Society for Leukocyte Biology.

Entities:  

Keywords:  NK cell; immunoregulation; tumor

Year:  2020        PMID: 33095941     DOI: 10.1002/JLB.3MR0820-685R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  10 in total

Review 1.  Innate Lymphoid Cells: Role in Immune Regulation and Cancer.

Authors:  Douglas C Chung; Nicolas Jacquelot; Maryam Ghaedi; Kathrin Warner; Pamela S Ohashi
Journal:  Cancers (Basel)       Date:  2022-04-21       Impact factor: 6.575

Review 2.  Natural killer cells: a promising immunotherapy for cancer.

Authors:  Junfeng Chu; Fengcai Gao; Meimei Yan; Shuang Zhao; Zheng Yan; Bian Shi; Yanyan Liu
Journal:  J Transl Med       Date:  2022-05-23       Impact factor: 8.440

Review 3.  Targeting natural killer cells to enhance vaccine responses.

Authors:  Andrew Cox; Hilal Cevik; H Alex Feldman; Laura M Canaday; Nora Lakes; Stephen N Waggoner
Journal:  Trends Pharmacol Sci       Date:  2021-07-23       Impact factor: 17.638

4.  Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.

Authors:  Fangshi Xu; Yibing Guan; Yubo Ma; Li Xue; Peng Zhang; Xiaojie Yang; Tie Chong
Journal:  Aging (Albany NY)       Date:  2021-04-21       Impact factor: 5.682

5.  Tumor-Experienced Human NK Cells Express High Levels of PD-L1 and Inhibit CD8+ T Cell Proliferation.

Authors:  Jessica M Sierra; Florencia Secchiari; Sol Y Nuñez; Ximena L Raffo Iraolagoitia; Andrea Ziblat; Adrián D Friedrich; María V Regge; M Cecilia Santilli; Nicolás I Torres; Mariana Gantov; Aldana Trotta; Carlos Ameri; Gonzalo Vitagliano; Hernando Ríos Pita; Luis Rico; Agustín Rovegno; Nicolás Richards; Carolina I Domaica; Norberto W Zwirner; Mercedes B Fuertes
Journal:  Front Immunol       Date:  2021-09-20       Impact factor: 7.561

6.  Identifying SARS-CoV-2 'memory' NK cells from COVID-19 convalescent donors for adoptive cell therapy.

Authors:  Lara Herrera; Myriam Martin-Inaraja; Silvia Santos; Marta Inglés-Ferrándiz; Aida Azkarate; Miguel A Perez-Vaquero; Miguel A Vesga; Jose L Vicario; Bernat Soria; Carlos Solano; Raquel De Paz; Antonio Marcos; Cristina Ferreras; Antonio Perez-Martinez; Cristina Eguizabal
Journal:  Immunology       Date:  2021-12-02       Impact factor: 7.215

Review 7.  Modulation of Macrophage Polarization by Viruses: Turning Off/On Host Antiviral Responses.

Authors:  Shaoxiong Yu; Hailiang Ge; Su Li; Hua-Ji Qiu
Journal:  Front Microbiol       Date:  2022-02-11       Impact factor: 5.640

8.  Biomedicine and traditional Chinese medicine: a fruitful scientific and cultural interaction.

Authors:  Lorenzo Mortara; Grace Coco; Cristina Pozzi
Journal:  Acta Biomed       Date:  2022-03-14

Review 9.  Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control.

Authors:  Nicole F Bernard; Sanket Kant; Zahra Kiani; Cécile Tremblay; Franck P Dupuy
Journal:  Front Immunol       Date:  2022-05-20       Impact factor: 8.786

Review 10.  Recruited and Tissue-Resident Natural Killer Cells in the Lung During Infection and Cancer.

Authors:  Miriam Franklin; Emma Connolly; Tracy Hussell
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.